Keros Therapeutics, Inc. (KROS)

NASDAQ: KROS · Real-Time Price · USD

11.10

+0.49 (4.62%)

At close: Aug 19, 2026, 4:00 PM EDT

11.16

+0.06 (0.54%)

Pre-market: Aug 20, 2026, 8:36 AM EDT

Keros Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 19, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	220	620	641	1,191	1,323	1,369
Market Cap Growth	-62.68%	-3.27%	-46.17%	-9.94%	-3.39%	-16.27%
Enterprise Value	-22	-56	130	918	1,084	1,149
Last Close Price	11.10	20.36	15.83	39.76	48.02	58.51

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 19, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	7.13	-	-	-	-
PS Ratio	14.66	2.54	180.63	7888.64	-	68.11
PB Ratio	0.84	2.05	1.12	3.59	4.77	5.63
P/TBV Ratio	0.84	2.05	1.12	3.59	4.77	5.63
P/FCF Ratio	-	5.85	-	-	-	-
P/OCF Ratio	-	5.77	-	-	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 19, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	-	-	36.57	6076.87	-	57.16

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 19, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.06	0.06	0.03	0.04	0.05	0.00
Debt / EBITDA Ratio	-	0.21	-	-	-	-
Debt / FCF Ratio	-	0.16	-	-	-	-
Net Debt / Equity Ratio	-0.92	-0.89	-0.95	-0.95	-0.96	-0.94
Net Debt / EBITDA Ratio	2.50	-3.75	2.58	1.87	2.33	4.09
Net Debt / FCF Ratio	4.99	-2.55	3.32	2.49	3.73	3.62
Asset Turnover	0.03	0.51	0.01	0	-	0.08
Quick Ratio	21.47	15.10	20.56	13.63	16.92	20.96
Current Ratio	21.96	15.45	21.45	14.25	17.27	21.23
Return on Equity (ROE)	-17.16%	19.90%	-41.46%	-50.19%	-40.22%	-23.27%
Return on Assets (ROA)	-11.78%	9.25%	-26.73%	-31.39%	-25.53%	-13.43%
Return on Invested Capital (ROIC)	-481.72%	211.85%	-916.80%	-1251.82%	-887.57%	-1027.86%
Return on Capital Employed (ROCE)	-35.70%	22.20%	-35.80%	-49.20%	-39.60%	-23.20%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 19, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-37.79%	14.03%	-29.22%	-12.84%	-7.91%	-4.29%
FCF Yield	-22.03%	17.08%	-25.39%	-10.66%	-5.39%	-4.61%
Buyback Yield / Dilution	33.15%	-1.13%	-27.13%	-16.66%	-8.17%	-50.48%

SEC Filings: 10-K · 10-Q